Literature DB >> 19200067

Spinal NK-1 receptor-expressing neurons and descending pathways support fentanyl-induced pain hypersensitivity in a rat model of postoperative pain.

Cyril Rivat1, Louis P Vera-Portocarrero, Mohab M Ibrahim, Heriberto P Mata, Nicola J Stagg, Milena De Felice, Frank Porreca, T P Malan.   

Abstract

The clinically important opioid fentanyl, administered acutely, enhances mechanical hypersensitivity in a model of surgical pain induced by plantar incision. Activity of neurokinin-1 (NK-1) receptor-expressing ascending spinal neurons, descending pathways originating in the rostral ventromedial medulla (RVM), and spinal dynorphin are necessary for the development and maintenance of hyperalgesia during sustained morphine exposure, suggesting that these mechanisms may also be important in opioid enhancement of surgical pain. Therefore, we examined the roles of these mechanisms in sensory hypersensitivity produced by acute fentanyl administration in rats not undergoing surgical incision and in rats undergoing plantar incision. In non-operated rats, fentanyl induced analgesia followed by immediate and long-lasting sensory hypersensitivity, as previously described. Fentanyl also enhanced pain sensitivity induced by plantar incision. Ablation of NK-1-expressing spinal neurons by pre-treatment with substance P-Saporin reduced sensory hypersensitivity in fentanyl-treated rats and, to a lesser extent, in fentanyl-treated rats with a surgical incision. Microinjection of lidocaine into the RVM completely reversed fentanyl-induced sensory hypersensitivity and fentanyl enhancement of incision-induced sensory hypersensitivity. RVM lidocaine injection resulted in a slight reduction of incision-induced sensory hypersensitivity in the absence of fentanyl pre-treatment. Spinal dynorphin content increased by 30 +/- 7% and 66 +/- 17% in fentanyl- and fentanyl/incision-treated rats. Spinal administration of antiserum to dynorphin attenuated sensory hypersensitivity in fentanyl-treated rats. These data support a partial role of NK-1 receptor-containing ascending pathways and a crucial role of descending facilitatory pathways in fentanyl-induced hyperalgesia and in the enhanced hyperalgesia produced by fentanyl treatment following surgical incision.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200067     DOI: 10.1111/j.1460-9568.2009.06616.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  32 in total

1.  Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity.

Authors:  Bo Lian; Louis Vera-Portocarrero; Tamara King; Michael H Ossipov; Frank Porreca
Journal:  Brain Res       Date:  2010-08-19       Impact factor: 3.252

2.  Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation.

Authors:  Suneeta Tumati; Tally M Largent-Milnes; Attila I Keresztes; Takashi Yamamoto; Todd W Vanderah; William R Roeske; Victor J Hruby; Eva V Varga
Journal:  Eur J Pharmacol       Date:  2012-06-05       Impact factor: 4.432

3.  Neurokinin 1 and opioid receptors: relationships and interactions in nervous system.

Authors:  Jie Xiao; Si Zeng; Xiangrui Wang; Hasan Babazada; Zhanchun Li; Renyu Liu; Weifeng Yu
Journal:  Transl Perioper Pain Med       Date:  2016

4.  Parabrachial Complex: A Hub for Pain and Aversion.

Authors:  Michael C Chiang; Anna Bowen; Lindsey A Schier; Domenico Tupone; Olivia Uddin; Mary M Heinricher
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

5.  Latent sensitization: a model for stress-sensitive chronic pain.

Authors:  Juan Carlos Marvizon; Wendy Walwyn; Ani Minasyan; Wenling Chen; Bradley K Taylor
Journal:  Curr Protoc Neurosci       Date:  2015-04-01

6.  Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain.

Authors:  Aswini Kumar Giri; Christopher R Apostol; Yue Wang; Brittany L Forte; Tally M Largent-Milnes; Peg Davis; David Rankin; Gabriella Molnar; Keith M Olson; Frank Porreca; Todd W Vanderah; Victor J Hruby
Journal:  J Med Chem       Date:  2015-10-30       Impact factor: 7.446

7.  Loss of neurons in rostral ventromedial medulla that express neurokinin-1 receptors decreases the development of hyperalgesia.

Authors:  S G Khasabov; D A Simone
Journal:  Neuroscience       Date:  2013-07-03       Impact factor: 3.590

8.  Morphine has latent deleterious effects on the ventilatory responses to a hypoxic challenge.

Authors:  Walter J May; Ryan B Gruber; Joseph F Discala; Veljko Puskovic; Fraser Henderson; Lisa A Palmer; Stephen J Lewis
Journal:  Open J Mol Integr Physiol       Date:  2013-11

9.  Preprotachykinin-A gene disruption attenuates nociceptive sensitivity after opioid administration and incision by peripheral and spinal mechanisms in mice.

Authors:  Peyman Sahbaie; Xiaoyou Shi; Xiangqi Li; Deyong Liang; Tian-Zhi Guo; Yanli Qiao; David C Yeomans; Wade S Kingery; J David Clark
Journal:  J Pain       Date:  2012-10       Impact factor: 5.820

10.  Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effects.

Authors:  T M Largent-Milnes; S W Brookshire; D P Skinner; K E Hanlon; D Giuvelis; T Yamamoto; P Davis; C R Campos; P Nair; S Deekonda; E J Bilsky; F Porreca; V J Hruby; T W Vanderah
Journal:  J Pharmacol Exp Ther       Date:  2013-07-16       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.